Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1Phase 1/2 1Phase 1 1

Status

Unknown 2Terminated 1

Sponsor Class

OTHER 2UNKNOWN 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 9Thoracic 8Gynecologic 7Genitourinary 6Other hematologic neoplasm 5Sarcoma 3Myeloid 3Lymphoid 3Gastrointestinal 3CNS 3Breast 3Other 2Classical hematology 2Dermatologic 1

Conditions

Rectal Neoplasms 1Locally Advanced Rectal Cancer 1Colorectal Neoplasms 1

Interventions

Oxaliplatin 780Fluorouracil 638Capecitabine 575Gemcitabine 478Leucovorin 459Bevacizumab 445Irinotecan 444Cisplatin 338Radiotherapy 283Cetuximab 252Paclitaxel 180S 1 (combination) 176pembrolizumab 173Docetaxel 156Drug Therapy 147Nivolumab 146sintilimab 143tislelizumab 131apatinib 131130-nm albumin-bound paclitaxel 128Folfox protocol 121durvalumab 119Albumin-Bound Paclitaxel 117camrelizumab 107lenvatinib 106Panitumumab 106regorafenib 102Surgical Procedures, Operative 102Sorafenib 99Radiation 88

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Amifostine × Gastrointestinal × Clear all
NCT00601198 2023-08-01

A Study of Amifostine (Ethyol) in Patients With Colorectal Cancer

University of Cincinnati

Phase 2 Terminated
4 enrolled 9 charts
Gastrointestinal

Colorectal Neoplasms

NCT03702985 2019-01-23

Radiation-protection Effect of Amifostine in Locally Advanced Rectal Cancer

Fudan University

Phase 2 Unknown
160 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer

NCT01586117 2013-08-15

A Phase II Study of Amifostine for the Prevention of Acute Radiation-Induced Rectal Toxicity

ChineseAMS

Phase 2 Unknown
40 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡